Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
<h4>Background</h4>Direct oral anticoagulants (DOACs) have emerged as promising alternatives to vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or venous thromboembolism (VTE). Few meta-analyses have included all DOACs that have received FDA approva...
Saved in:
| Main Authors: | Raghavendra Charan P Makam, David C Hoaglin, David D McManus, Victoria Wang, Joel M Gore, Frederick A Spencer, Richeek Pradhan, Hoang Tran, Hong Yu, Robert J Goldberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0197583 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01) -
Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation
by: Nicholas W. Lange, et al.
Published: (2025-01-01) -
Direct oral anticoagulant approvals by four major regulatory agencies: a cross-sectional analysis of premarket and postmarket evidence
by: Joseph S Ross, et al.
Published: (2024-10-01) -
Anticoagulant-induced oral bleeding
by: Victor Costa, et al.
Published: (2017-09-01) -
Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)